Investor Type | Firm |
Industries | Other • BioTech |
Investing | Singapore |
Investment Range | $41,120,000 - $41,120,000 |
Olympus Capital Holdings Asia is an independent private equity firm that invests in middle-market companies across Asia, including regions such as China, India, Southeast Asia, South Korea, and Japan. The firm, founded in 1997 and based in Singapore, operates with a dual focus on providing both equity and private debt capital solutions to its investment targets. They are actively involved in sectors such as Manufacturing, Healthcare Services, Agribusiness & Food, Financial & Business Services, and Environmental & Clean Energy. With an investment strategy that includes an operational partnership approach, Olympus Capital Holdings Asia works closely with portfolio companies to build successful businesses. Their investment profile is characterized by extensive cross-border capabilities, leveraging expertise in multiple markets to drive growth and value creation. They also have a strong commitment to social responsibility and sustainable investing, as evidenced by several portfolio companies receiving recognition for social responsibility initiatives. The firm boasts a stable and experienced senior leadership team and maintains local teams across strategic locations in Hong Kong, Shanghai, New Delhi, and Singapore, in addition to the headquarters. Over the course of its operation, Olympus Capital Asia has invested more than $2.6 billion of equity capital on behalf of its funds and co-investors in over 65 portfolio companies throughout the region. The firm's approach to investment is highlighted by a long track record in Asia spanning over 20 years, demonstrating a deep understanding of the unique market dynamics and investment landscape across the Asian economies. They offer a single investment size of approximately $41,120,000, which underlines their focus on middle-market opportunities.